Table 1 Association between SETD6 expression and clinicopathologic features
From: Investigating the functional role of SETD6 in lung adenocarcinoma
Variables | Number of patients | SETD6 expression (%) | P | |
|---|---|---|---|---|
Low/none | High | |||
Total | 45 | 13 (28.9) | 32 (71.1) | |
Gender | ||||
Male | 29 | 10 (34.5) | 19 (65.5) | 0.3223 |
Female | 16 | 3 (18.8) | 13 (81.2) | |
Age | ||||
< 60 | 13 | 8 (61.5) | 5 (38.5) | 0.0039** |
≥ 60 | 32 | 5 (15.6) | 27 (84.4) | |
Smoking index | ||||
> 400 | 17 | 7 (41.2) | 10 (58.8) | 0.1884 |
< 400 | 28 | 6 (21.4) | 22 (78.6) | |
TNM stage | ||||
I-II | 25 | 9 (36.0) | 16 (64.0) | 0.3271 |
III-IV | 20 | 4 (20.0) | 16 (80.0) | |
Regional lymph node metastasis | ||||
Yes | 28 | 4 (14.3) | 24 (85.7) | 0.0083** |
No | 17 | 9 (52.9) | 8 (47.1) | |
Tumor size | ||||
≥ 3 cm | 26 | 5 (19.2) | 21 (80.8) | 0.1114 |
< 3 cm | 19 | 8 (42.1) | 11 (57.9) | |